Purpose To investigate the prevalence of myopic macular degeneration (MMD) in the global population.
Methods All published literature of population-based studies on MMD prevalence worldwide were searched and only those with clear definitions to diagnose and classify MMD lesions by standardised grading methods were selected. Meta-analysis methods were used to calculate the pooled prevalence of MMD and its 95% CI in a random-effects model. The prevalence of MMD lesions would also be reported, together with the subgroup analysis of age, region and gender. Correlation between MMD prevalence and spherical equivalent levels and axial length were also evaluated.
Results 12 studies with 58 558 subjects were included in this meta-analysis. The pooled prevalence of MMD in the world population was 2.1% (95% CI: 1.3% to 3.3%). In the subgroup analysis, people with the following characteristics were at higher risk of developing MMD: female, urban life, living in Asia, older age, longer axial length and severer myopia.
Conclusions MMD is a serious public health concern worldwide, particularly in subjects who are women, subjects living in urban areas, subjects living in Asia, and subjects with longer axial lengths and severer myopia. Further studies from other continents/ethnicities are needed for comprehensive estimates of the prevalence of MMD globally.
- myopic macular degeneration
Statistics from Altmetric.com
MZ and SW are joint first authors.
Contributors GJ and DZ: designed the study, initiated the collaborative project, revised the paper. MZ, SW and ZL: monitored data collection, wrote the statistical analysis plan and drafted the paper. AC, CAY and YZ: cleaned and analysed the data. GJ and DZ: administrative, technical or logistic support.
Funding This work was supported by National Natural Science Foundation of China (81873673, 81900841) and the Fundamental Research Funds of the State Key Laboratory of Ophthalmology.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement Data are available upon reasonable request. Data are available upon reasonable request to email firstname.lastname@example.org.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.